Investigation of immunohistochemical ERα, ERβ and ERβcx expressions in normal and neoplastic breast tissues

Pathology Research and Practice

Volumn 208, Issue 3, 2012, Pages 133-139

  Bozkurt, Kemal Kürşat ^a   Kapucuoĝlu, Nilgün ^a  

^a SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Breast cancer; ER ; ER ; ER cx; Immunohistochemistry

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGEN RECEPTOR BETA CX; FORMALDEHYDE; PARAFFIN; PROGESTERONE RECEPTOR; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CARCINOGENESIS; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; LYMPH VESSEL; PHENOTYPE; POSTMENOPAUSE; PREMENOPAUSE; PROTEIN EXPRESSION; TISSUE FIXATION; TUMOR VOLUME;

ADULT; AGED; BREAST; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PROTEIN ISOFORMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84858073978     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2011.12.015     Document Type: Article

References (50)

1. Balfe P., McCann A., McGoldrick A., McAllister K., Kennedy M., Dervan P., et al. Estrogen receptor alpha and beta profiling in human breast cancer. Eur. J. Surg. Oncol. 2004, 30:469-474.
2. Beatson G.T. On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment with illustrative cases. Lancet 1896, 2:104-107.
3. Bernstein L., Ross R.K. Endogenous hormones and breast cancer risk. Epidemiol. Rev. 1993, 15:48-65.
4. Carder P.J., Murphy C.E., Dervan P., Kennedy M., McCann A., Saunders P.T.K., et al. A multi-centre investigation towards reaching a consensus on the immunohistochemical detection of ERβ in archival formalin-fixed paraffin embedded human breast tissue. Breast Cancer Res. Treat. 2005, 92:287-293.
5. Carter D., Connolly J., Ellis I.O., Eusebi V., Finkel G., Gorstein F., et al. Consensus conference on the classification of ductal carcinoma in situ. Hum. Pathol. 1997, 28:1221-1225.
6. Cowley S.M., Parker M.G. A comparison of transcriptional activation by ERα and ERβ. J. Steroid Biochem. Mol. Biol. 1999, 69:165-175.
7. Enmark E., Pelto-Huikko M., Grandien K., Lagerkrantz S., Lagerkrantz J., Fried G., et al. Human estrogen receptor beta gene structure, chromosomal localization and expression pattern. J. Clin. Endocrinol. Metab. 1997, 82:4258-4265.
8. Elston C.W., Ellis I.O. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991, 19:403-410.
9. Esslimani-Sahla M., Simony-Lafontaine J., Kramar A., Lavaill R., Mollevi C., Warner M., et al. Estrogen receptor beta (ERbeta) level but not its ERbetacx variant helps to predict tamoxifen resistance in breast cancer. Clin. Cancer Res. 2004, 10:5769-5776.
10. Esslimani-Sahla M., Kramar A., Simony-Lafontaine J., Warner M., Gustafsson J.-A., Rochefort H. Increased estrogen receptor βcx expression during mammary carcinogenesis. Clin. Cancer Res. 2005, 11:3170-3174.
11. Fuqua S.A.W., Schiff R., Parra I., Moore J.T., Mohsin S.K., Osborne C.K., et al. Estrogen receptor beta protein in human breast cancer: correlation with clinical tumor parameters. Cancer Res. 2003, 63:2434-2439.
12. Green C.A., Peter M.B., Speirs V., Shaaban A.M. The potential role of ERβ isoforms in the clinical management of breast cancer. Histopathology 2008, 53:374-380.
13. Greene F.L., Page D.L., Fleming I.D., Fritz A., Balch C.M., Haller D.G., et al. AJCC Cancer Staging Manual 2002, Springer-Verlag, New York. 6th edition.
14. Gruvberger-Saal S.K., Bendahl P.O., Saal L.H., Laakso M., Hegardt C., Eden P., et al. Estrogen receptor beta expression is associated with tamoxifen response in ERalpha-negative breast carcinoma. Clin. Cancer Res. 2007, 13:1987-1994.
15. Gustafsson J.A., Warner M. Estrogen receptor beta in the breast: role in estrogen responsiveness and development of breast cancer. J. Steroid Biochem. Mol. Biol. 2000, 74:245-248.
16. Honma N., Takubo K., Akiyama F., Kasumi F., Sawabe M., Arai T., et al. Expression of oestrogen receptor-beta in apocrine carcinomas of the breast. Histopathology 2007, 50:425-433.
17. Honma N., Horii R., Iwase T., Saji S., Younes M., Takubo K., et al. Clinical importance of estrogen receptor-β evaluation in breast cancer patients treated with adjuvant tamoxifen therapy. J. Clin. Oncol. 2008, 26:3727-3734.
18. Honma N., Saji S., Kurabayashi R., Aida J., Arai T., Horii R., et al. Oestrogen receptor-beta-1 but not oestrogen receptor-beta-cx is of prognostic value in apocrine carcinoma of the breast. APMIS 2008, 116:923-930.
19. Jarvinen T.A.H., Pelto-Huikko M., Holli K., Isola J. Estrogen receptor beta is coexpressed with ERalpha and PR and associated with nodal status, grade, and proliferation rate in breast cancer. Am. J. Pathol. 2000, 156:29-35.
20. Khan S.A., Rogers M.A., Khurana K.K., Meguid M.M., Numan P.J. Estrogen receptor expression in benign breast epithelium and breast cancer risk. J. Natl. Cancer Inst. 1998, 90:37-42.
21. Lewandowski S., Kalita K., Kaczmarek L. Estrogen receptor β, potential functional significance of a variety of mRNA isoforms. FEBS Lett. 2002, 524:1-5.
22. Leygue E., Dotzlaw H., Watson P.H., Murphy L.C. Expression of estrogen receptor beta1, beta2, and beta5 messenger RNAs in human breast tissue. Cancer Res. 1999, 59:1175-1179.
23. Mann S., Laucirica R., Carlson N., Younes P.S., Ali N., Younes A., et al. Estrogen receptor beta expression in invasive breast cancer. Hum. Pathol. 2001, 32:113-118.
24. Menasce L.P., White G.R., Harrison C.J., Boyle J.M. Localization of the estrogen receptor locus (ESR) to chromosome 6q25.1 b FISH and a simple post-FISH banding technique. Genomics 1993, 17:263-265.
25. Miller K. Estrogen and DNA damage: the silent source of breast cancer?. J. Natl. Cancer Inst. 2002, 95:100-102.
26. Miller W.R., Anderson T.J., Dixon J.M., Saunders P.T. Oestrogen receptor beta and neoadjuvant therapy with tamoxifen: prediction of response and effects of treatment. Br. J. Cancer 2006, 94:1333-1338.
27. Murphy L., Cherlet T., Lewis A., Banu Y., Watson P. New insights into estrogen receptor function in human breast cancer. Ann. Med. 2003, 35:614-631.
28. Murphy L.C., Watson P.H. Is oestrogen receptor-beta a predictor of endocrine therapy responsiveness in human breast cancer?. Endocr. Relat. Cancer 2006, 13:327-334.
29. Nakopoulou L., Lazaris A.C., Panayotopoulou E.G., Giannopoulou I., Givalos N., Markaki S., et al. The favourable prognostic value of oestrogen receptor {beta} immunohistochemical expression in breast cancer. J. Clin. Pathol. 2004, 57:523-528.
30. Omoto Y., Inoue S., Ogawa S., Toyama T., Yamashita H., Muramatsu M., et al. Clinical value of the wild-type estrogen receptor beta expression in breast cancer. Cancer Lett. 2001, 163:207-212.
31. Omoto Y., Kobayashi S., Inoue S., Ogawa S., Toyama T., Yamashita H., et al. Evaluation of estrogen receptor β wild-type and variant protein expression and relationship with clinicopathological factors in breast cancer. Eur. J. Cancer 2002, 38:380-386.
32. O'Neill P.A., Davies M.P.A., Shaaban A.M., Innes H., Torevell A., Sibson D.R., et al. Wild-type oestrogen receptor beta (ERbeta1) mRNA and protein expression in tamoxifen-treated postmenopausal breast cancers. Br. J. Cancer 2004, 91:1694-1702.
33. Palmieri C., Cheng G.J., Saji S., Zelada-Hedman M., Wärri A., Weihua Z., et al. Estrogen receptor beta in breast cancer. Endocr. Relat. Cancer 2002, 9:1-13.
34. Palmieri C., Lam E.W.-F., Mansi J., MacDonald C., Shousha S., Madden P., et al. The expression of ERβcx in human breast cancer and the relationship to endocrine therapy and survival. Clin. Cancer Res. 2004, 10:2421-2428.
35. Roger P., Daures J.P., Maudelonde T., Pignodel C., Gleizes M., Chapelle J., et al. Dissociated overexpression of cathepsin-D and estrogen receptor α in preinvasive mammary tumors. Hum. Pathol. 2000, 31:593-600.
36. Roger P., Esslimani-Sahla M., Makela S., Gustafsson J.A., Baldet P., Rochefort H. Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors. Cancer Res. 2001, 61:2537-2541.
37. Rosai J. Breast. Rosai and Ackerman's Surgical Pathology 2004, 1763-1876. Mosby, New York. 9th edition. J. Rosai (Ed.).
38. Saji S., Omoto Y., Shimizu C., Warner M., Hayashi Y., Horiguchi S., et al. Expression of estrogen receptor (ER) betacx protein in ERalphapositive breast cancer: specific correlation with progesterone receptor. Cancer Res. 2002, 62:4849-4853.
39. Saji S., Hirose M., Toi M. Clinical significance of estrogen receptor beta in breast cancer. Cancer Chemother. Pharmacol. 2005, 56:21-26.
40. Shaaban A.M., O'Neill P.A., Davies M.P., Sibson R., West C.R., Smith P.H., et al. Declining estrogen receptor-β expression defines malignant progression of human breast neoplasia. Am. J. Surg. Pathol. 2003, 27:1502-1512.
41. Shoker B.S., Jarvis C., Clarke R.B., Anderson E., Hewlett J., Davies M.P.A., et al. Estrogen receptor-positive proliferating cells in the normal and precancerous breast. Am. J. Pathol. 1999, 155:1811-1815.
42. Skliris G.P., Carder P.J., Lansdown M.R.J., Speirs V. Immunohistochemical detection of ER-beta in breast cancer: towards more detailed receptor profiling?. Br. J. Cancer 2001, 84:1095-1098.
43. Skliris G.P., Parkes A.T., Limer J.L., Burdall S.E., Carder P.J., Speirs V. Evaluation of seven oestrogen receptor beta antibodies for immunohistochemistry, Western blotting, and flow cytometry in human breast tissue. J. Pathol. 2002, 197:155-162.
44. Sobin L.H., Wittekind C. TNM Classification of Malignant Tumors 2002, Wiley-Liss, New York. 6th edition.
45. Speirs V., Parkes A.T., Kerin M.J., Walton D.S., Carleton P.J., Fox J.N., et al. Coexpression of estrogen receptor alpha and beta: poor prognostic factors in human breast cancer?. Cancer Res. 1999, 59:525-528.
46. Speirs V., Malone C., Walton D.S., Kerin M.J., Atkin S.L. Increased expression of estrogen receptor beta mRNA in tamoxifen-resistant breast cancer patients. Cancer Res. 1999, 59:5421-5424.
47. Speirs V. Oestrogen receptor beta in breast cancer: good, bad or still too early to tell?. J. Pathol. 2002, 197:143-147.
48. Speirs V., Carder P.J., Lane S., Dodwell D., Lansdown M.R.J., Hanby A.M. Oestrogen receptor β: what it means for patients with breast cancer. Lancet Oncol. 2004, 5:174-181.
49. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J. Natl. Cancer Inst. 2002, 94:606-616. The Endogenous Hormones and Breast Cancer Collaborative Group.
50. Younes M., Honma N. Estrogen receptor β. Arch. Pathol. Lab. Med. 2011, 135:63-66.